SMARCC1 Suppresses Tumor Progression by Inhibiting the PI3K/AKT Signaling Pathway in Prostate Cancer

Abstract

<i>SMARCC1</i> suppresses PCa cell proliferation and metastasis <i>via</i> the <i>PI3K/AKT</i> signaling pathway and is a novel therapeutic target.